Syringeability of nonaqueous parenteral formulations--development and evaluation of a testing apparatus
Chien, Y.W.; Przybyszewski, P.; Shami, E.G.
Journal of Parenteral Science and Technology a Publication of the Parenteral Drug Association 35(6): 281-284
1981
ISSN/ISBN: 0279-7976 PMID: 7320817 Document Number: 179181
Document emailed within 1 workday
Related Documents
Bohrer, D.; Do Nascimento, P.C.íc.; Becker, E.; Bortoluzzi, F.; Depoi, F.; de Carvalho, L.M. 2004: Critical evaluation of the standard hydrolytic resistance test for glasses used for containers for blood and parenteral formulations PDA Journal of Pharmaceutical Science and Technology 58(2): 96-105Sadana, B.; Chabra, C. 2004: Development and sensory evaluation of low cost weaning food formulations Journal of Human Ecology 16(2): 133-136
Giacoia, G.P.; Taylor-Zapata, P.; Mattison, D. 2007: Need for appropriate formulations for children: the national institute of child health and human development-pediatric formulations initiative, part 2 International journal of pharmaceutical compounding 11(3): 220-221
Pandey, S.; Basheer, M.; Roy, S.; Udupa, N. 1999: Development and evaluation of transdermal formulations containing metronidazole and norfloxacin for the treatment of burn wound Indian Journal of Experimental Biology 37(5): 450-454
Skrzypczak, J.; Pisarski, T.; Biczysko, W. 1980: Evaluation of the development of granulosa cells in the follicular apparatus of the ovaries of human fetuses Ginekologia Polska 51(10): 885-894
Heyman, M.B. 1990: General and specialized parenteral amino acid formulations for nutrition support Journal of the American Dietetic Association 90(3): 401-8 411
Strickley, R.G. 1999: Parenteral formulations of small molecules therapeutics marketed in the United States (1999)--Part i PDA Journal of Pharmaceutical Science and Technology 53(6): 324-349
Strickley, R.G. 2000: Parenteral formulations of small molecules therapeutics marketed in the United States (1999). Part IIi PDA Journal of Pharmaceutical Science and Technology 54(2): 152-169
Rayaprolu, B.Madhavi.; Strawser, J.J.; Anyarambhatla, G. 2018: Excipients in parenteral formulations: selection considerations and effective utilization with small molecules and biologics Drug Development and Industrial Pharmacy 44(10): 1565-1571
Beijnen, J.H.; van Gijn, R.; Challa, E.E.; Kaijser, G.P.; Underberg, W.J. 1992: Chemical stability of two sterile, parenteral formulations of cyclophosphamide (Endoxan) after reconstitution and dilution in commonly used infusion fluids Journal of Parenteral Science and Technology: a Publication of the Parenteral Drug Association 46(4): 111-116
Hongo, H.; Green, J.; Otsuka, K.; Jimba, M. 2013: Development and psychometric testing of the Japanese version of the maternal breastfeeding evaluation scale Journal of Human Lactation: Official Journal of International Lactation Consultant Association 29(4): 611-619
Van Tienen, A.; Hullegie, Y.M.; Hummelen, R.; Hemsworth, J.; Changalucha, J.; Reid, G. 2011: Development of a locally sustainable functional food for people living with HIV in Sub-Saharan Africa: laboratory testing and sensory evaluation Beneficial Microbes 2(3): 193-198
Bobrov, B.S.; Zolkin, I.P.; Itkin, G.P.; Parashin, V.B.; Khrushchev, A.A. 1977: Hydrodynamic stands for testing assisted circulation and artificial heart apparatus Meditsinskaia Tekhnika 6: 43-47
Guilfoyle, D.E.; Yager, J.F. 1984: Procedures used for sterility testing of parenteral drugs by an FDA field laboratory Journal of Parenteral Science and Technology: a Publication of the Parenteral Drug Association 38(4): 138-141
Hoffmann, G.E.; Schenker, M.; Kammann, M.; Meyer-Lüerssen, D.; Wilke, M.H. 2004: The significance of laboratory testing for the German diagnosis-related group system--the systematic evaluation of comorbidities of relevance to case reimbursement and continued development of the DRG Watchdog software Clinical Laboratory 50(9-10): 599-607
Regazzi, B.M.; Rondanelli, R.; Ciaroelli, L.; Bartoli, A.L.; Rampini, A. 1986: Evaluation of the absorption from three ibuprofen formulations International Journal of Clinical Pharmacology Research 6(6): 469-473
Schmidt, P.C.; Kaupp, H. 1993: Stability and new formulations of hexetidine. 2. Formulations and in vitro bioavailability Die Pharmazie 48(11): 837-841
Garg, S.; Kandarapu, R.; Vermani, K.; Tambwekar, K.R.; Garg, A.; Waller, D.P.; Zaneveld, L.J.D. 2003: Development pharmaceutics of microbicide formulations. Part I: preformulation considerations and challenges Aids Patient Care and Stds 17(1): 17-32
Feil, M.C. 1983: More on nonaqueous controls for blood gas determinations Clinical Chemistry 29(10): 1859-1860
Cai, Y.; Li, Y.; Li, S.; Gao, T.; Zhang, L.; Yang, Z.; Fan, Z.; Bai, C. 2016: Level a in Vitro-In-Ivo Correlation Development and Valida- Tion for Tramadol Hydrochloride Formulations Acta Poloniae Pharmaceutica 73(5): 1333-1338